XML 23 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Shareholders' Equity
 9 Months Ended
Apr. 28, 2017
Shareholders' Equity [Abstract]  
Shareholders' Equity
6.
Shareholders' Equity

During the nine months ended April 28, 2017, the Company issued 86,439 shares of its common stock resulting from the vesting of share-based compensation awards and stock option exercises.  Related tax withholding payments on these share-based compensation awards exceeded proceeds received from the exercise of stock options, which resulted in a net reduction to shareholders' equity of $6,031.

During the nine months ended April 28, 2017, total share-based compensation expense was $6,347.  The excess tax benefit realized upon exercise of share-based compensation awards was $1,203.

During the nine months ended April 28, 2017, the Company paid regular dividends of $3.45 per share of its common stock and declared a regular dividend of $1.15 per share of its common stock that was paid on May 5, 2017 to shareholders of record on April 14, 2017.

The following table summarizes the changes in AOCL, net of tax, related to the Company's interest rate swaps for the nine months ended April 28, 2017 (see Notes 2 and 5):
 
  
Changes in AOCL
 
AOCL balance at July 29, 2016
 
$
(13,740
)
Other comprehensive income before reclassifications
  
11,783
 
Amounts reclassified from AOCL
  
(2,071
)
Other comprehensive income, net of tax
  
9,712
 
AOCL balance at April 28, 2017
 
$
(4,028
)

The following table summarizes the amounts reclassified out of AOCL related to the Company's interest rate swaps for the quarter and nine months ended April 28, 2017:

  
Amount Reclassified from AOCL
 
Affected Line Item in the
  
Quarter Ended
  
Nine Months Ended
 
Condensed Consolidated
Financial Statements
Loss on cash flow hedges:
         
Interest rate swaps
 
$
(993
)
 
$
(3,354
)
Interest expense
Tax benefit
  
380
   
1,283
 
Provision for income taxes
  
$
(613
)
 
$
(2,071
)
Net of tax